Waitforit! Indeed we shall, and for those of us who have stayed the coarse because we can see the potential of the science Will Be Rewarded in the short-term (relatively speaking) by years end -- and my hope is then a forth coming buyout at or above $4 billion.
This may seem optimistic, but if you calculate the worth of a platform that opens the door to non-responders in multiple cancer indications.